Navigating FDA’s 2026 AI Medical Device Guidance
On January 12, 2026, the U.S. Food and Drug Administration (FDA) is expected to release its updated guidance for Artificial Intelligence (AI) and Machine Learning (ML) Software as a Medical Device (SaMD), signaling a pivotal shift for regulated industries that develop, deploy, or integrate AI-enable
